On the Couch with Scott Kirkland (ASX: EMV): The Future of Stroke Diagnosis Starts Here
About this episode
Henry Jennings interviews Scott Kirkland about the future of stroke diagnosis and the work of EMVision Medical Devices.
Welcome to another episode of On the Couch. In this episode, Henry Jennings catches up with Scott Kirkland from EMVision Medical Devices (ASX: EMV). Scott is the co-founder of EMVision Medical Devices Ltd and has held several senior sales roles, including Head of Client Sales at US-based technology company Quantcast, before founding Kirkland Capital to focus on emerging technologies. At EMVision, Scott oversees corporate affairs, commercial strategy, and business development, while also manag...
People in this episode
Host: Henry Jennings
Guest: Scott Kirkland
Topics covered
- stroke diagnosis
- medical technology
- business development
- emerging technologies
- corporate strategy
Keywords
- stroke diagnosis
- medical devices
- Scott Kirkland
- EMVision
- business development
- emerging technologies
Mentioned in this episode
Organizations: EMVision Medical Devices, Quantcast, Kirkland Capital, ASX: EMV
More episodes of On the Couch
- On the Couch with Nick Griffin (Munro Partners): Markets, AI and Global Tech Themes
- Ask the Analyst | 17 April
- Why the Next Six Months Could Get Tough for Small Caps: On the Couch with Chris Stott
- On the Couch with Coby Hanoch (Weebit Nano): The Memory Boom Behind AI
- On the Couch With Richard Morrow (Lowell Resources): Talking Gold and Gold Stocks
- On the Couch with Gary Norden: Inside a 35-Year Trading Career
Explore listener stats, chart rankings, contacts and more on the On the Couch podcast page.